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Identity 
Other names: EC 6.3.2.-; LUN; 
OTTHUMP00000021182; OTTHUMP00000021184; 
OTTHUMP00000045227; P53BP3; RP31; TP53BPL; 
p53BP3 




Spans approximately 8kbs of DNA in the reverse strand 
of chromosome 9. 
Transcription 
Two splicing variants. 
Transcript 1 (ENST00000360538): Transcript length 
4145 bps, three exons, first one non-coding. 
Transcript 2 (ENST00000379858): Transcript length 





TOPORS transcript 1 encodes a protein containing 
1,045 amino acids (ENSP00000353735). 
TOPORS transcript 2 encodes a protein containing 980 
amino acids (ENSP00000369187). 
The 1045aa human TOPORS contains a RING family 
zinc-finger domain and a leucine zipper (LZ) domain in 
the N-terminal. It also possesses a C-terminal bipartite 
nuclear localization signal (NLS), five sequences rich 
in proline, glutamine, serine and threonine (PEST 






The two splicing variants of TOPORS are shown. Transcript 1 (ENST00000360538) has three exons, the first one non-coding. Transcript 
2 (ENST00000379858) has two exons, the first one non-coding. The coding regions are shown in yellow boxes and the non-coding 
regions (untranslated regions, UTRs) are shown in open boxes. 
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Homology between murine Topors and human TOPORS is 
shown. The N-terminal Ring-finger (RF, red) and leucine zipper 
(LZ, green) domains show 93% homology and the C-terminal 
nuclear localization signal (NLS, blue) domain shows 90% 
homology between mouse and human. The P53 binding 
regions of TOPORS, located inside the NLS domain, are 
highlighted with red lines. 
Function 
The RING finger protein TOPORS contains a RING 
family zinc-finger domain, a putative leucine zipper 
(LZ) domain, five sequences rich in proline, glutamine, 
serine and threonine (PEST sequences), an 
arginine/serine (RS) domain and a bipartite nuclear 
localization signal (NLS). TOPORS was first identified 
as a human topoisomerase I-interacting protein by yeast 
two-hybrid screening (Haluska et al., 1999). TOPORS 
is localized in the nucleus and has been reported to be 
closely associated with the PML bodies (Weger et al., 
2003; Rasheed et al., 2002). An important role of 
TOPORS is its ability to interact with the tumor 
suppressor protein P53 (Zhou et al., 1999). Forced 
expression of murine Topors during DNA damage 
stabilizes p53, enhances the p53-dependent 
transcriptional activities of waf1, MDM2 and Bax 
promoters and elevates the level of endogenous p21waf1 
mRNA (Lin et al., 2005). These findings suggest an 
anti-oncogenic role for TOPORS. Indeed, it was shown 
that TOPORS expression is decreased or undetectable 
in colon adenocarcinomas relative to normal colon 
tissue, and the protein level of TOPORS is undetected 
in several colon cancer cell lines (Saleem et al., 2004). 
Repression of TOPORS expression was also reported 
in progression and development of non-small cell lung 
cancer (Oyanagi et al., 2004). 
Furthermore, loss of heterozygosity in the region 9p21, 
the chromosomal locus harboring TOPORS, has been 
frequently associated with different malignancies (Puig 
et al., 2005). A high-resolution genomewide mapping 
study identified deletion of the TOPORS genomic 
locus in human glial tumors, suggesting a possible role 
for TOPORS in gliomagenesis (Bredel et al., 2005). A 
missense mutation in the TOPORS gene was 
implicated in autosomal dominant pericentral retinal 
dystrophy, showing that mutations in the TOPORS 
gene can lead to genetic disorders (Selmer et al., 2009). 
Concomitant with these observations, point mutations 
and small insertions and deletions in the TOPORS gene 
was found to cause approximately 1% of autosomal  
 
dominant retinitis pigmentosa (Bowne et al., 2008). 
Another study reported that mutations in TOPORS 
cause autosomal dominant retinitis pigmentosa with 
perivascular retinal pigment epithelium atrophy 
(Chakarova et al., 2007). 
Valuable information on the cellular roles for TOPORS 
came through several biochemical studies. It was 
shown that in the nucleus TOPORS undergoes SUMO-
1 modifications (Weger et al., 2003). Interestingly, 
TOPORS itself has the ability to sumoylate other 
proteins by functioning as a SUMO-1 E3 ligase. For 
example, TOPORS can sumoylate p53 and the 
chromatin modifying protein Sin3A (Shinbo et al., 
2005; Weger et al., 2005; Pungaliya et al., 2007). 
Furthermore, TOPORS induce the accumulation of 
polysumoylated forms of DNA topoisomerase I in vitro 
and in vivo (Hammer et al., 2007). Intriguingly, apart 
from its role as a SUMO-1 E3 ligase, TOPORS can 
also function as an E3 ubiquitin ligase. In fact, 
TOPORS was the first example of a protein that 
possesses dual-roles as an E3 ligase for sumoylation 
and ubiquitination of other proteins. It was reported 
that Topors works as an E3 ubiquitin ligase with 
specific E2 enzymes to ubiquitinate the p53 protein and 
the prostrate tumor suppressor protein NKX3.1 
(Rajendra et al., 2004; Guan et al., 2008). Intense 
investigations have been undertaken in recent years to 
elucidate the mechanisms of molecules that have dual 
E3 ligase activities for sumoylation and ubiquitination 
such as TOPORS. These studies have discovered a new 
family of proteins, designated as the small ubiquitin-
related modifier (SUMO)-targeted ubiquitin ligases 
(STUbLs), which directly links sumoylation and 
ubiquitination (Perry et al., 2008). It has been 
suggested that similar to STUbLs, TOPORS may be 
recruited to its targets through SUMO-associated 
interactions and stimulate their ubiquitination in a 
RING finger-dependent manner (Perry et al., 2008). 
Furthermore, TOPORS has been connected with 
transcriptional regulation because of its role as an E3 
ubiquitin ligase. In drosophila, the homolog of human 
TOPORS (dTopors) ubiquitinates the Hairy 
transcriptional repressor, suggesting that TOPORS 
could be involved in regulating other transcription 
factors as well (Secombe et al., 2004). Indeed, it was 
shown that TOPORS interacts with the adeno-
associated virus type 2 (AAV-2) Rep78/68 proteins and 
enhances the expression of a Rep78/68 dependent 
AAV-2 gene in the absence of the helper virus (Weger 
et al., 2002). Finally, it was shown that drosophila 
dTopors was required for the nuclear organization of a 
chromatin insulator, suggesting a role for TOPORS in 
regulation of the chromatin (Capelson et al., 2005). 
Homology 
Widely conserved among different species. Murine 
Topors shows high similarity with human TOPORS. 
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Mutations 
Germinal 
TOPORS has been implicated in autosomal dominant 
pericentral retinal dystrophy (adPRD), an atypical form 
of retinitis pigmentosa. Retinitis pigmentosa is the 
collective name for a group of genetically induced eye 
disorders that are frequenctly associated with night 
blindness and tunnel vision. The TOPORS gene was 
sequenced in 19 affected members of a large 
Norwegian family. A novel missense mutation, 
c.1205a>c, resulting in an amino acid substitution 
p.Q402P, was found in all of the cases. Furthermore, 
the mutation showed complete co-segregation with the 
disease in the family, with the LOD score of 7.3. This 
mutation was not detected in 207 unrelated and healthy 
Norwegian subjects (Selmer et al., 2009). A separate 
study showed that mutations in the TOPORS gene are 
responsible for autosomal dominant retinitis 
pigmentosa (adRP). Mutations that included an 
insertion and a deletion were identified in two adRP-
affected families (Chakarova et al., 2007). Finally, 
another recent study investigated whether mutation(s) 
in the TOPORS gene is associated with autosomal 
dominant retinitis pigmentosa (adRP). The frequency 
of TOPORS mutation was analyzed in an adRP cohort 
of 215 families and two different mutations, namely, 
p.Glu808X and p.Arg857GlyfsX9, were identified. 
This study concluded that point mutations and small 
insertions or deletions in TOPORS may cause 
approximately 1% of adRP (Bowne et al., 2008). 
Implicated in 
Non-small cell lung cancer (NSCLC) 
Disease 
Non-small cell lung cancer (NSCLC) is the major form 
of lung cancer, with a frequency of 80~90% of all lung 
carcinomas. NSCLCs are usually classified into three 
groups, namely, squamous cell carcinoma, 
adenocarcinoma and large-cell carci-noma. The 
squamous cell carcinoma is linked with smoking and 
accounts for approximately 25~30% of all lung 
cancers, which are usually found in the middle of the 
lungs or near a bronchus. Adenocarci-noma is 
frequently spotted in the outer part of the lungs and is 
thought to be responsible for ~40% of all lung cancers. 
About 10~15% of lung cancers are large-cell 
carcinomas, which can start in any part of the lung and 
has the ability to grow and spread quickly, making this 
type of lung cancers difficult to treat. 
Oncogenesis 
Expression of TOPORS was found to be signifi-cantly 
repressed in lung cancer tissues compared to normal 
lung tissues. TOPORS gene expression was slightly 
down-regulated along with progression of primary 
tumors, and strongly downregulated along with nodal 
metastases. Interestingly, in normal tissues TOPORS 
gene expression was down-regulated in smokers 
(Oyanagi et al., 2004). These findings show that there 
is a reverse correlation between NSCLC and TOPORS 
expression and suggest that TOPORS may act as a 
tumor sup-pressor gene for lung cancers. 
Glial brain tumor 
Disease 
Glial brain tumors arise from glial cells and are highly 
lethal. Glial brain tumors include astrocytomas, 
oligodendrogliomas and oligoastro-cytomas. 
Oncogenesis 
A recent study investigated copy number alterations of 
42,000 mapped human cDNA clones in a series of 54 
gliomas of varying histogenesis and tumor grade by 
comparative genomic hybridization technology. This 
study reported a set of genetic alterations 
predominantly associated with either astrocytic or 
oligodendrocytic tumor phenotype. Among these 
genetic alterations, a minimally deleted region 
containing the TOPORS gene was identified, 
suggesting a role for TOPORS in gliomagenesis 
(Bredel et al., 2005). 
Colon cancer 
Disease 
Cancerous growth in colon, rectum or the appendix are 
collectively addressed as colon cancer or colorectal 
cancer. This is the third most frequent form of cancer 
and a major cause of cancer-related death all over the 
world. 
Oncogenesis 
TOPORS expression is decreased or undetected in 
colon adenocarcinomas compared to normal colon 
tissues. Furthermore, TOPORS protein is not detectable 
in several colon cancer cell lines, suggesting an anti-
oncogenic role for TOPORS (Saleem et al., 2004). 
Autosomal dominant retinitis 
pigmentosa (adRP) 
Disease 
Autosomal dominant retinitis pigmentosa (adRP) is a 
form of retinitis pigmentosa, a collective title for a 
group of genetically induced eye disorders that are 
frequenctly associated with night blindness and tunnel 
vision. 
Prognosis 
Mutations and small insertions or deletions of the 
TOPORS gene have been associated with adRP. 
TOPORS has been associated with autosomal dominant 
pericentral retinal dystrophy (adPRD), which has a 
favorable prognosis compared to classical retinitis 
pigmentosa (RP). A novel mis-sense mutation, 
c.1205a>c, resulting in an amino acid substitution 
p.Q402P, was observed in all affected members of a 
large Norweigian family (Selmer et al., 2009). In 
another study, an adRP cohort of 215 families was 
investigated and two different mutations, namely, 
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p.Glu808X and p.Arg857GlyfsX9, were identified 
(Bowne at al., 2008). TOPORS has also been 
implicated in autosomal dominant retinitis pigmentosa 
with perivascular retinal pigment atrophy, a disorder 
that showed a distinct phenotype at the earlier stage of 
the disease, with an unusual perivascular cuff of retinal 
pigment epithelium atrophy, which was found 
surrounding the superior and inferior arcades in the 
retina. This study reported mutations in the TOPORS 
gene that included an insertion and a deletion was 
identified in two adRP-affected families (Chakarova et 
al., 2007). 
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